NCT00387023
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT00387023
NCT00722488
NCT01110824
NCT00462787
NCT00483262
NCT00317811
NCT00335647
NCT00274976
NCT00006383
NCT01037517